Anti-BCMA CAR-T cells
anti-BCMA CART
Phase 1 mab active
Quick answer
Anti-BCMA CAR-T cells for Multiple Myeloma is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Multiple Myeloma
- Phase
- Phase 1
- Modality
- mab
- Status
- active